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Treatment of acrodermatitis conlinua of Hallopeau (ACH) is difficult and often disappointing. 
We describe a patient with an extensive ACH of all finger- and toetips, who was treated with
acitretin combined with calcipotriol. A within-subjee comparison was carried out be e t a
tween calcipotriol ointment (50 pg/g) and the ointment base to investigate the additional value 
o f  calcipotriol above the ointment base. The side treated with calcipotriol as adjunct therapy 
showed an impressive improvement, well beyond 
with the ointment base only.
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Fig. 1. Acrodermatitis continua o f  Hallopeau before treatment Fig. 2. Acrodermatitis continua of Hallopeau after 1 month of 
with acitretin and calcipotriol. A Right hand. B Left hand. combined treatment with acitretin 35 mg/day and placebo ointment
-  ~  a .  -  a  a  m a A  m Æ _
twice daily (A, right hand) or calcipotriol twice daily (B, left hand).
We describe a patient with an exten- steroids, crude coal tar, UVB and UVB com- cated erythematous, indurated lesions with
sive ACH of all finger- and toetips, improv- bined with dithranol had been ineffective, pustule formation
ing during combined treatment with acitretin treatment with calcipotriol 50 pg/g Acitretin was re-introduced in a dosage of
and calcipotriol. The present case report monotherapy during 3 weeks did not result in 35 mg/day (0.5 mg/kg) once daily. Because 
suggests a synergistic effect of combi na- improvement of the lesions. Before attending of a moderate cheilitis, hair loss and a dry
tion of acitretin and topical calcipotriol in our hospital, the patient had been treated with skin, it was not possi to increase
ACH. acitretin 35 mg/day (0.5 mg/kg) during 3 dosage of acitretin further. On the lesions of 
months. Initially, acitretin had a beneficial ef-
Case Report
hand and loot calcipotriol 50 pg/g 
feet on lesions on the body but no effect on ointment (Daivonex®, Leo Pharmaceutical 
the acral lesions. Treatment with acitretin Products. Weesp, the Netherlands) was ap- 
was discontinued because of the lack of fur- plied twice daily. On the
A 73-year-old woman presented with a 3- ther improvement. placebo ointment (Leo Pharmaceutical Prod »
year history of redness, scaling and pustula- On clinical examination, 3 months was ap i
M
tion of all the finger-and toetips. From time discontinuation o f  acitretin treatment, the pa- o f  combined treatment, a substantial ini
to time, she had also pustular eruptions else- tient presented with erythema and scaling at provement of the lesions at the
where on the body. The lesions appeared for the dorsal side of the distal phalanges of all treated sides was present (fig.2A). However,
the first time on the elbows and on one finger fingers and toes. Most nail plates were absent the calcipotriol-treated side was far more ini
as discrete pustular changes and rapidly pro- and the nail beds showed multiple pustules, proved (fig. 2B). Pustulation
gressed to a disabling condition. Prior to dis- from pinhead size to a lew millimetres (fig. 1).
ease onset, there was no history of trauma All digits were equally involved. In addition,
or infection. Treatment with potent topical on elbows, legs and knees sharply demar-
358 Dermatology 1996; 192:357-359
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Discussion topical calcitriol has been demonstrated in atively long persistence of other infiltrate
ACH is difficult to treat, which is re-
chronic plaque psoriasis [11|.
Several groups have studied the effect of
cells [181.
So far, we can only speculate on the puta-
flected in several reports on different treat- acitretin and calcipotriol on the polymor- tive synergism of calcipotriol and acitretin. 
ment modalities applied in ACH. No con- phonuclear leucocytes (PMN), the cells that Further controlled studies are worthwhile to 
trolled studies have been performed and most dominate in pustular psoriasis. Acitretin explore to what extent the combination of 
communications are casuistic. Local thera- 2 5 -7 5  mg/day inhibits the in vivo migration both treatments has to be recommended, 
pies, which are reported to be effective, com- of PMN using leukotriene-B4-induced intra­
prise coal tar preparations [2], dithranol [2], epidermal accumulation of PMN as an in
fluorouracil [3] and mechlorethamine [4]. vivo model [9, 12, 13]. In vitro, acitretin in- 
Systemic treatments which may be effective hibits the migration of PMN but does not in- 
are systemic steroids [5], methotrexate [2], terfere with arachidonic acid release by these
Acknowledgements
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ciclosporin A [6,7], etretinate [1,8,9] and the cells [14,15]. Calcipotriol has been shown to Leo Pharmaceutical Products, Weesp, the
inhibit the release of arachidonic acid from Netherlands, for providing the study oint-non-s 
[10].
am nu
the PMN [16] and to inhibit chemotaxis in ment and H.M. Bruns, denm
The present case report illustrates the pos- vitro [17]. During treatment psoriatic doom, the Netherlands, for
sible additional effect of calcipotriol oint- plaques with calcipotriol, PMN faded from si on. 
ment above systemic treatment with acitretin the psoriatic plaque already during the 
in ACH. A synergistic effect of etretinate and first week of treatment, in contrast to the rel-
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